Today: 13 April 2026
Boeing Stock Debate Widens as Bullish $290 Target Meets Debt, Certification Risk
23 March 2026
2 mins read

Boeing Stock Debate Widens as Bullish $290 Target Meets Debt, Certification Risk

NEW YORK, March 23, 2026, 10:23 EDT

Boeing climbed $4.30 to $199.42 in early U.S. trading Monday. Debates over how to price the stock, though, only got messier. A new TipRanks report highlighted a sharp divide among AI models over Boeing’s outlook—this just days after Yahoo Finance ran a bullish argument and Tigress Financial bumped up its price target.

Why does the split matter now? Boeing needs higher deliveries and a hefty order book to finally drive positive free cash flow—what’s left after capital spending—a big shift after years tangled in safety issues, supply chain snags and production setbacks. Eyes are on certification of the 737 MAX 10 and 777-9; every sign-off pushes up deliveries, pulls in cash, and adds fuel to the recovery story for the stock.

The three articles each tackle the same underlying tug-of-war, though with different emphases. Thursday brought a bullish argument for Boeing via a Yahoo Finance piece using Insider Monkey as its source. On Friday, Tigress raised its 12-month target from $275 to $290. Then Monday, TipRanks pointed out that even their brighter outlooks left little room for error if Boeing stumbles on execution.

Tigress analyst Ivan Feinseth sees Boeing riding a “multi-decade expansion in commercial air traffic” and notes its “growing high-margin aftermarket and digital offerings.” He called out recent numbers as evidence for stronger scale, improved profitability, healthier cash flow and clearer demand trends. tipranks.com

Boeing’s outlook still comes down to execution. Last week, Chief Financial Officer Jay Malave said the company is aiming to boost 737 MAX production to 47 per month “sometime mid-year,” with around 500 deliveries of the jet planned for 2026 and certification for the MAX 7 and MAX 10 still targeted for the second half. Several systems remain to be tested before the Federal Aviation Administration gives its approval, Malave noted. Reuters

Some progress, though no finish line yet. Boeing’s 777-9 has gotten FAA approval to advance into the fourth certification phase as of last week, while Ryanair’s Michael O’Leary said he’s betting on a third-quarter signoff for the 737 MAX 10. That model is Boeing’s pitch against the A321neo from Airbus—a narrow-body jet that’s already built up years of lead time and flight history.

For the bulls, the numbers speak for themselves. Back in January, Boeing reported a commercial backlog above 6,100 jets, pegged at an all-time high of $567 billion. Reuters noted Boeing pulled ahead of Airbus in net orders for 2025 — something it hasn’t managed in seven years — though Airbus still held the edge in deliveries. Leeham’s Scott Hamilton called the order book a “vote of confidence” for Boeing’s ongoing turnaround. Boeing Investors

The bearish view hasn’t gone anywhere. Boeing last week delayed its commercial airplane unit’s return to profit until 2027. TipRanks, meanwhile, flagged issues like high debt, slim profit margins, lumpy cash flow, and ongoing execution risks in its lower-ranked models. The debt stack stood at $54.1 billion by the end of 2025. Analyst Robert Mann called out engine woes, describing the latest models as “more problematic and inefficient than expected.” Reuters

The mood skews bullish, but with a measure of caution. As of March 12, Reuters stock data showed 29 analysts had Outperform-type calls on Boeing. On Monday, Jefferies’ Sheila Kahyaoglu stuck with her Buy rating and a $295 price target. Boeing shares climbed that day, but what comes next probably depends on certification, deliveries, and any fresh cash-flow color.

Stock Market Today

  • Monash IVF Shares Surge 16% Following New Takeover Bid
    April 12, 2026, 9:56 PM EDT. Monash IVF, Australia's second-largest fertility services provider, saw its shares jump nearly 16% to 77 cents after a takeover offer valued at 90 cents per share surfaced, representing a 35% premium over recent stock prices. The bid, from WHSP Holdings and Genesis Capital, is unsolicited and conditional, aiming for exclusive access to the company's financial records and unanimous board support. Monash IVF has faced challenges including embryo implantation errors in Melbourne and Brisbane, leading to regulatory actions and an independent review. The company is currently assessing the proposal with financial and legal advisors, but no transaction is assured. Monash IVF holds approximately 19% market share of the assisted reproduction sector, which accounts for about one in 18 Australian births annually, increasing to one in ten for mothers over 35.

Latest article

Bitcoin Price Today Slips After Iran Talks End Without Deal, but ETF Buyers Keep Showing Up

Bitcoin Price Today Slips After Iran Talks End Without Deal, but ETF Buyers Keep Showing Up

12 April 2026
Bitcoin fell 1.4% to $71,707 on Sunday after U.S.-Iran talks in Islamabad ended without a deal. Spot bitcoin ETFs logged net inflows last week, with BlackRock and Fidelity leading Friday’s buying. Morgan Stanley launched its MSBT fund on April 8, the first Wall Street bank to debut a bitcoin ETF. U.S. inflation data showed headline CPI up 3.3% in March, while core CPI rose 2.6%.
XRP Price Today: XRP Slips to $1.33 After Failed U.S.-Iran Talks Hit Crypto

XRP Price Today: XRP Slips to $1.33 After Failed U.S.-Iran Talks Hit Crypto

12 April 2026
XRP slipped about 1% to $1.33 on Sunday after U.S.-Iran peace talks in Islamabad ended without a deal, pressuring crypto markets. The token traded in a narrow range, with bitcoin and ether also weaker. XRP’s market cap stands at $81.7 billion, with $1.96 billion in daily volume. The token remains 63.5% below its all-time high.
Gold Price Today: Bullion Near $4,762 After Weekly Gain, but Failed Iran Talks Cloud Outlook

Gold Price Today: Bullion Near $4,762 After Weekly Gain, but Failed Iran Talks Cloud Outlook

12 April 2026
Spot gold steadied at $4,761.79 an ounce Friday after a third weekly gain, with U.S. futures at $4,787.40. The dollar posted its biggest weekly drop since January, making gold cheaper for non-U.S. buyers. U.S.-Iran talks ended without a deal, keeping geopolitical risks high. China’s central bank increased gold reserves for a 17th month, reaching 74.38 million ounces.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 12.04.2026

12 April 2026
Futu Holdings (FUTU) rose 10.2% in the past week but trades 13.4% below its January level. Shares closed at $154.50, while analysts estimate intrinsic value at $245.48. The company posted a 92.2% return over 12 months. Valuation models indicate earnings exceed risk costs, supporting long-term growth projections.
India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

11 April 2026
Lockheed Martin said it is not in direct talks with India over the F-35, clarifying that any approach must go through official U.S. and Indian channels under the Foreign Military Sales process. Indian officials confirmed no formal discussions on acquiring the F-35 have begun. India recently approved a $40 billion military upgrade, including other fighter jets, while Lockheed’s F-21 remains in a separate competition.
Meta Stock Pullback Reopens Value Debate Despite Strong Q4 and Huge AI Bill
Previous Story

Meta Stock Pullback Reopens Value Debate Despite Strong Q4 and Huge AI Bill

Nasdaq Composite Rebounds as Oil Tumbles; Merlin Gains After Index Addition
Next Story

Nasdaq Composite Rebounds as Oil Tumbles; Merlin Gains After Index Addition

Go toTop